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A generally-held beliefby both the medical profession
and the lay public is that therapeutic medicine greatly
affects health. Providing more hospital beds, doctors
and resources is viewed as the path to improve health.
Therapeutic medicine is of much benefit to sick
people. However, with the exception of several highly
contagious infections, it has not reduced the incidence
of disease. This generalization applies particularly to
cancer. Despite this fact most ofthe expense and effort
devoted to the management of cancer is directed
towards early diagnosis (screening) and improved
therapy. Evidence has steadily accrued that this
strategy is essentially a failure: little impact has been
made on the toll taken by the major cancers.
The failure oftherapy, coupled with the realization
that the overwhelming majority of cancer is related
to environmental, particularly lifestyle, factors,
dictates that prevention should be our foremost aim.
It follows, therefore, that cancer research should
concentrate on those environmental factors which
may cause or prevent cancer. Instead, most research
looks at either the detailed mechanisms of cancer
formation or else investigates new types of therapy.
Medicine should admit its severe limitations in
therapy and redirect itself. Using the fruits of an
expanded research programme into such areas as diet
and exercise, medicine should strive to apply this
knowledge to cancer prevention.
How successful is the war agat cancer?
C'est magnifique mais ce n'est pas la guerre
As is well known, there have been major improvements
in survival rates for certain cancers of children and
young adults'. However, since only about 1.3% of
cancer cases occur in those under 25 years2, this has
little impact on the overall picture. In other cancers,
lymphomas and breast cancer for example, various
advances in treatment have been achieved.
Early detection appears to be of value against two
major cancers ofwomen. The Papanicolaou smear has
apparently cut the mortality for cervical cancer in
countries with well organized screening programmes3.
A total of four randomized screening studies have
shown that mammography in women aged about
50 years or over can reduce breast cancer mortality
by 20-30%4-8. Hewitt9 and others, however, have
questioned the extent of the benefit. Even if one
accepts the results of the above trials, they hold no
promise for most women destined to develop the
disease. Moreover, the large number offalse positives
associated with mamography causes much trauma.
One cancer where early detection may prove to be of
value is colon cancer, particularly if screening
methods improve.
While these examples do represent success stories,
albeit limited ones, when the field ofcancer as a whole
is surveyed, -a generally depressing picture emerges.
In their 1981 study of preventable cancer in the
USA, Doll and Peto'0 stated that there may have
been no improvement in survival from the common
cancers since the early 1950s. More recently Cairns1'
argued that there has been no real advance in
survival rates for the major cancers. These claims
stand in stark contrast to the 'official' figures for the
USA. These indicate that since the 1950s significant
progress has been made in the 5-year survival rates
for most cancers" 12. However, critics have pointed to
two major flaws in the way survival rates are
calculated'0""'3"4. Each ofAthese flaws reflect the
greatly increased use of screening to detect several
cancers at an earlier stage.
First, we have the problem of lead-time bias'4. Let
us suppose a particular cancer is invariably fatal and
that in previous years death always occurred 4 years
after clinical symptoms forced the patient to a doctor.
Let us further suppose that early diagnosis now
causes the cancer to be diagnosed two years earlier,
but treatment is never successful. The result of early
diagnosis will be that the survival time ofeach patient
(measured from diagnosis) will.jump from four years
to six. Even more impressive, the five year survival
rate will jump from zero to 100%! Something of this
has actually occurred.
The second flaw in the survival figures is that
screening causes much over-diagnosis10""',13. Many
of the early 'cancers' detected by screening and
subsequently 'cured' are not, in fact, destined to
develop any ofthe clinical symptoms of a true cancer.
This problem applies particularly to cancer of the
lung, breast and prostate,
It is important not to lose sight of the harm done
by the above two problems (early diagnosis ofcancers
destined to be fatal and the over-diagnosis of 'cancer').
Each case exposes the patient to much unnecessary
emotional -distress and unpleasant treatment.
Bailar and Smith13 took a different approach to the
question of whether we are successful in the war on
cancer. Rather than focusing on survival rates they
looked at the changes in overall mortality since 1950
in the USA. This led them to a similarly pessimistic
conclusion: 'Che data) provide no evidence that some
35 years of intense and growing efforts to improve
the treatment of cancer have had much overall O141O76891/
effect on the most fumdamental measure of clinical 02095-04/$02 00/0
outcome - death. Indeed, with respect to cancer -as a © 199,
whole, we have slowly lost ground, as shown by the The Royal
rise in age-adjusted mortality rates in the entire Society of
population'. Medicine
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A recent study from West Germany came to the
same conclusion. The authors reported that there
is no real evidence that between 1952 and 1985
improvements in treatment had any significant effect
on overall cancer mortality'5.
Overall, therefore, little real success has been
achieved in the war against cancer. True increases
in survival rates have appeared in only a few cancers.
Increases in age-adjusted mortality rates have wiped
out any gains.
We also see this by contrasting the meagre
improvements in survival rates with the far greater
changes in the age-adjusted mortality rates in the
USA. Between 1930 and 1985 mortality from stomach
cancer fell by about 85% and that from uterine
cancer by about 77%1. Simultaneously, there was an
explosion in lung cancer. Lesser rises were seen for
leukaemia and cancer of the prostate, pancreas and
ovary. The volatile nature of the different cancers is
illustrated by the changing ratio of stomach cancer
deaths to lung cancer deaths: 9: 1 in 1930, 1: 10. in
1985. The causes ofthese dramatic changes lie almost-
entirely in environmental, particularly lifestyle,
factors. Clearly, improvements in medical treatment
are of little importance compared with environmental
factors.
Over the last several decades, then, medicine has
waged a major war against cancer, concentrating on
earlier diagnosis and improved therapy. The war is
not being won. Nevertheless, medicine shows few
signs of admitting that its strategy may be flawed.
In this it resembles a World War I general who
stated: 'Casualties: huge. Ground gained: negligible.
Conclusion: press on.'
Cancer: a preventable disease
The enormous differences in the incidence of particular
forms of cancer in differing geographical and socio-
economic situations, together with the changing
incidences following emigration from high to low risk
areas, or vice versa, indicate the major role of
environmental factors. It is reckoned that the vast
majority of cancer is related to -the environment,
particularly lifestyle10"16. These observations suggest
that much cancer must be potentially preventable, if
the responsible environmental factors could be
reduced or eliminated. In many instances causative
factors have been identified and preventive action
recommended, eg lung cancer from smoking and skin
cancer from excessive sunshine.
Breast and colorectal cancers, two ofthe commonest
tumours of Western populations, are rare in popu-
lations whose lifestyle is pre-industrial. Each cancer
has comparable prevalences in black and white
Americans, and increases dramatically in populations
that emigrate from areas of low to areas of high
prevalence, as in the case ofJapanese immigrants to
Hawaii'0"17. Breast cancer is about eight times as
common in black American women as in African
women'7, and colon cancer is nearly 15 times as
common in black Americans as in Africans18. This
underlines the dependence of these cancers on the
environment of Western culture.
Tumours of the lung, colon and prostate are by
far the most common cancers in man, while tumours
of the breast, lung and colon are the most common
in women. These are, if one adds endometrial cancer,
the tumours that are characteristic of Western
culture and affluence. Because these tumours share
epidemiological features, namely geography, socio-
economic status and chronological emergence, with
a large group of disorders now referred to collectively
as Western diseases, they must be assumed to share
common or related causative factors'9. Therefore, the
same measures recommended for avoiding diseases
varying from coronary heart disease to diverticular
disease, from gall stones to hiatus hernia, from
diabetes to obesity, to name but a few, should also
apply to colon and breast cancer.
Cancer research
For the main thrust of the war on cancer to be
prevention, research into cancer must reveal how this
can most effectively be done. Unfortunately, most
cancer research is misdirected.
In a previous paper by one of us, medical research
was divided into -two types20. Most research is
'complex'; it involves studying intricate- body
mechanisms in health and disease and attempting to
gain a real understanding of the disease process. A
minority of research is 'simple'. Here the major
activity is to determine which environmental or
lifestyle factors cause or prevent diseases. It also
includes studies of simple body mechanisms (eg the
effect of dietary fibre on intestinal transit time).
The major tools of simple research are population
studies, prospective and case-control studies, experi-
mental intervention in humans (eg changing the diet
to test the effect on health) or analogous studies on
animals. The key feature of simple research is that
the results are immediately and-directly relevant to
our understanding of the disease.
The reason for the inferiority of complex research
is that disease processes are immensely complex. The
history of medical research over recent decades is not
one of understanding disease. Rather it is of finding
huge numbers of small pieces of gigantic jigsaw
puzzles. Whenever there appears to be light at the end
of the tunnel, this nearly always turns into more
tunnel where the light should be.
Areas such as immunology, molecular genetics and
cellular biology have seen impressive numbers of
discoveries. Yet rarely does this knowledge tell us
what changes in our lifestyle are likely to help
prevent or treat particular diseases. These problems
apply particularly to cancer research.
A classic example of the advantages of simple
research is the discovery that the great majority of
lung cancer patients smoke21'22. By further use of
simple research (prospective and case-control studies)
it was a straightforward matter to establish that
tobacco causes a whole group of other cancers.
Not surprisingly, researchers became intrigued as
to the mechanism by which smoking causes cancer.
Analysis of cigarette smoke revealed some 2000
chemicals. A large effort has gone into elucidating the
metabolism of these chemicals and how they cause
cancer. However, the- research effort, has faced
tremendous obstacles. To determine exactly how or
why this happens will take an army of researchers
many decades.
During the last few years simple research also led
to the important discovery that passive smoking
causes various diseases, including lung cancer23.
Similarly, the recent finding that cigarettes may be
the biggest single known cause ofleukaemia was the
result of case-control studies24,25. Complex research
contributed nothing to these discoveries. Indeed, it
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undoubtedly had a delaying effect by diverting
attention from a full investigation into the effects of
smoking on health.
More advantages of simple research are shown by
dietary studies. We will concentrate on two examples,
though the same lesson is learned from numerous
others.
The hypothesis that colon cancer can be prevented
by dietary fibre was based on epidemiology and the
known effects of fibre on colon function (ie an
increase in faecal bulk and a speeding of the transit
time)26 27. These actions of fibre, it was hypothesized,
reduce the exposure of the colon to carcinogens and
thereby prevent colon cancer. Here we have an
example where mechanisms may be looked at without
straying from simple research.
Support for the fibre concept has come from
prospective and case-control studies and from deter-
mining whether fibre prevents colon cancer in
animals28. Of course, over the years the hypothesis
has had to be modified, but this merely reflects new
information coming from simple research.
We do not believe that complex research has
significantly contributed to the story. Areas such as
identifying carcinogens in the faeces, determining
their metabolism and their effects on the colonic
mucosa have yielded little useful information.
Beta-carotene is another important protective factor
against cancer. This was first proposed by Peto et
al.29 in 1981 based on data coming almost entirely
from simple research. First, they reinterpreted
prospective and case-control studies and pointed out
that beta-carotene intake apparently has an inverse
relationship to cancer risk. Second, several animal
experiments had indicated that beta-carotene is
anti-carcinogenic.
Fortunately, the large majority of the subsequent
work has been by simple research (ie mostly pros-
pective and case-control studies)30. The mostly
positive results have indicated that beta-carotene
protects against several types of cancer, particularly
lung cancer.
Thus simple research into beta-carotene has provided
much important information on the prevention of
cancer. Had the research been confined to biochemistry
and allied techniques (complex research), it seems
highly likely that the anti-carcinogenic action ofbeta-
carotene would have been postponed by several
decades.
The large body of useful information discovered in
just a few years of simple research into beta-carotene
should be contrasted with the great 'in' area of
modern cancer research: molecular genetics. It now
accounts for a sizeable fraction of cancer research: the
resources devoted to molecular genetics (even when
narrowed just to that directly related to cancer)
probably outstrips all research on dietary factors in
cancer by a factor of two or three.
Molecular genetics is, in the main, another attempt
at producing a 'magic bullet' against cancer. Like its
predecessors (eg interferon), it offers great promise,
at least in theory. However, the track record of such
quests is extremely poor. The reason lies in the
inherent flaws in the logic of complex research, as
discussed earlier. The fact that it took almost 30 years
between the discovery of the double helix and the
emergence of oncogenes as a distinct research field
(1953 to the early 1980s) suggests that several more
decades will elapse before valuable new treatments
based on molecular genetics can emerge. It seems
highly probable, therefore, that molecular genetics is
destined to be the greatest ever Pied Piper of cancer
research.
Towards an integrated plan
for cancer control
There is need for a major reappraisal of how the
problem of cancer is approached. Prevention, rather
than early diagnosis and treatment, should be the top
priority. Prevention has the great advantage that it
eentails nothing worse than nicotine withdrawal
symptoms. On the other hand, cancer treatment, even
when successful, often exposes the patient to much
suffering, both physical and psychological. Indeed,
some cancer treatments are considered worse than the
disease.
An integrated plan for cancer control must also
research how cancer can be prevented. This objective
necessitates a far greater emphasis on simple
research.
For simple research to reach accurate conclusions
as to the factors which cause or prevent cancer, it
should use several types of investigation in parallel:
(1) population comparisons, (2) prospective and
case-control studies, (3) controlled clinical trials,
(4) analogous studies on animals, and (5) envis-
aging a plausible mechanism. However, just as guilt
can be established in a murder trial without a motive
being demonstrated, so a mechanism is not an
essential ingredient in proving the hypothesis under
test. Indeed, the hunt for a mechanism can quickly
enter a quagmire of complex research. Sometimes,
however, a mechanism presents itself without loss of
simplicity (eg dietary fibre and colon cancer).
Each of the above types of study has its pros and
cons. Forming a clear picture is best achieved by
combining the evidence from all five types of study.
A crucial area of research which we feel has been
badly neglected is behaviour modification. Few people
can be unaware that smoking is dangerous, yet a
large minority still smoke. Here is an urgent need for
research into appropriate anti-smoking strategies.
Similar research is needed in other areas, particularly
diet.
It would be myopic to view cancer in isolation from
other degenerative, particularly Western, diseases.
There is a great overlap between the factors which
cause or prevent all Western diseases. Moreover,
a prevention campaign is likely to be far more
successful in motivating people if the goal is the
prevention of the diseases that cause 80% mortality
(all Western disease) rather than those that cause 21%
(cancer only). For these reasons, the prevention of
cancer should be part of a major campaign to prevent
Western diseases in general. Medicine, it must be
pointed out, has a poor ability to cure virtually any
of the Western diseases.
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